Diatech Pharmacogenetics Announces Investment from TA to Fuel Strategic Growth Initiatives
TA’s investment supports Diatech’s expansion of precision medicine diagnostics to the global market JESI, MARCHE, Italy–(BUSINESS WIRE)–Diatech Pharmacogenetics (“Diatech” or “the Company”), a leader in pharmacogenetics and cancer precision medicine diagnostics, today announced that TA Associates (“TA”), a leading global private equity firm, has signed a definitive agreement to make a strategic growth investment in … [Read more…]
